Facial Lipoatrophy: Appearances Are Not Deceiving

Author(s)

Sanches, Roberta Seron ^[1] ; Mill, Judy ^[2] ; Machado, Alcyone Artioli ^[3] ; Donadi, Eduardo Antonio ^[3] ; Morais Fernandes, Ana Paula ^[1]

Affiliation

^[1] Univ Sao Paulo, Coll Nursing Ribeirao Preto, Dept Gen & Specialized Nursing, BR-05508 Sao Paulo - Brazil

^[2] Univ Alberta, Edmonton, AB - Canada

^[3] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-05508 Sao Paulo - Brazil

• Document type: Journal article
• Source: JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE; v. 20, n. 3, p. 169-175, MAY-JUN 2009.
• Web of Science Citations: 5

Abstract

Lipodystrophy syndrome (LS) has been reported as visible markers that cat? identify HIV status. Changes in body shape are detrimental in terms of psychological welfare and may affect well-being and increase the stigma associated with HIV disease. In the current study, the pychosocial impact of LS was evaluated. A total of 84 HIV-infected patients receiving antiretroviral therapy and exhibiting dyslipidemia were interviewed in an urban hospital setting in Brazil in 2006 using a standardized questionnaire. Of the 84 patients exhibiting dyslipidemia, 40 patients also exhibited body changes, and of these, 25 had facial lipoatrophy. From a psychosocial perspective, patients presenting with facial lipoatrophy reported alterations in self-image and self-esteem and believed that other people noticed their body changes. The results are relevant for nurses who need to be well-prepared to recognize lipodystrophy, to implement nursing interventions including lifestyle changes, and to provide psychosocial support to patients with LS. (AU)

• FAPESP's process: 04/08388-9 - Polymorfism of the tumoral necrosis factor in antiretroviral associated lipodystrophy syndrome in HIV-1-infected patients
• Grantee: Ana Paula Morais Fernandes
• Support Opportunities: Regular Research Grants